Exchange: OTC·Updated 08:02 AM EDT

PARD Poniard Pharmaceuticals, Inc.

$0.0001
$0.00
(0.00%)
Pre-Market
Prev Close $0.0001
Mkt Cap$150.00
Vol1.00

About PARD

Poniard Pharmaceuticals, Inc. engages in the development and commercialization of oncology products. The company was founded on May 11, 1984 and is headquartered in Seattle, WA.
50

Neutral Sentiment

How do you feel about PARD?

Advertisement|Remove ads.